2 active not recruiting, 1 enrolling by invitation, 1 recruiting. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Active not recruiting 2, Enrolling by invitation 1, Recruiting 1 |
Follow cenerimod: new trials by email Literature Review of cenerimod trials Research Report on cenerimod
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment Cenerimod, Placebo - Nephritis, Lupus, Lupus Erythematosus, Systemic | Phase 3 | Recruiting | Viatris Innovation GmbH | 300 | 2026-02-09 | 2026-07-30 |
| Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus Cenerimod - Lupus Erythematosus, Systemic | Phase 3 | Enrolling by invitation | Viatris Innovation GmbH | 680 | 2024-07-30 | 2026-09-11 |
| A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus Cenerimod, Placebo - Lupus Erythematosus, Systemic | Phase 3 | Active not recruiting | Viatris Innovation GmbH | 451 | 2023-06-26 | 2026-10-30 |
| A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus Cenerimod, Placebo - Lupus Erythematosus, Systemic | Phase 3 | Active not recruiting | Viatris Innovation GmbH | 470 | 2022-12-13 | 2026-10-30 |
Lupus Erythematosus, Systemic (4) · Autoimmune Diseases (3) · Connective Tissue Diseases (3) · Immune System Diseases (3) · Lupus Nephritis (1) · Skin and Connective Tissue Diseases (1)
United States (4) · Mexico (3) · Philippines (3) · Poland (3) · Ukraine (3) · Argentina (2) · Brazil (2) · Bulgaria (2) · Chile (2) · Colombia (2) · Czechia (2) · France (2) · Georgia (2) · Germany (2) · Greece (2)